Welcome: Guest | Site Use Options | Register | Login |

B-MOGEN Biotechnologies Inc

Profile last edited on: 9/13/19
1621 East Hennepin Avenue Suite B-15
Minneapolis, MN 55414
  (612) 309-7653
  info@bmogen.com
  www.bmogen.com
Business Identifier: Custom tools for gene delivery and gene editing
Public Profile:
In June 2019 it was announced that Bio-Techne Corporation (NASDAQ: TECH) - with a track record of several small firm acquisitions - had reached agreement to acquire all of the stock of B-MoGen Biotechnologies Inc . B-Mogen is a four-year old University of Minnesota genome engineering startup start-up already having grown to some 20 employees. Working on the most complex gene editing problems with proprietary, cutting edge gene editing and delivery tools, B-Mogen is enabling and accelerating growth in immunotherapy treatments utilizing cutting edge gene editing and gene delivery technologies to create unique research solutions and disease models in human cell. The firm has several SBIR awards already taken and underway and has entered into strategic partnerships with biotechnology companies, completed projects for clients in academia and industry, along with having successfully licensed and developed novel intellectual property focused on genome engineering.

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :

Unlock access

To unlock access to all SBIR-STTR company Profiles, a FREE site registration is required. Click here to register or login if you already have an account

Smart Office Options

SBIR firms in the news



Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920

  support@inknowvation.com